Beyond RECIST: How oncology imaging is evolving towards quantitative imaging biomarkers

This article will consider how oncology imaging is evolving towards quantitative biomarkers, considering what this looks like in practice, and how an imaging CRO with a long lasting proven track record in oncological clinical trials can enhance effective integration